249 related articles for article (PubMed ID: 4057200)
1. Pulmonary hypertension in systemic lupus erythematosus: effect of vasodilators on pulmonary hemodynamics.
Mahowald ML; Weir EK; Ridley DJ; Messner RP
J Rheumatol; 1985 Aug; 12(4):773-7. PubMed ID: 4057200
[TBL] [Abstract][Full Text] [Related]
2. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis.
Menon N; McAlpine L; Peacock AJ; Madhok R
Arthritis Rheum; 1998 Mar; 41(3):466-9. PubMed ID: 9506575
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary hypertension in systemic lupus erythematosus.
Gladman DD; Sternberg L
J Rheumatol; 1985 Apr; 12(2):365-7. PubMed ID: 4032410
[TBL] [Abstract][Full Text] [Related]
4. [Effect of the calcium antagonist nifedipine on central and peripheral hemodynamics in patients with primary pulmonary hypertension].
Khosseĭn A; Mareev VIu; Ageev FT; Sazonova LN; Lobova NM
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(1):78-81. PubMed ID: 3401345
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of the effects of vasodilator therapy in primary pulmonary hypertension. Experience in 7 cases].
Lanzarini L; Gavazzi A; Mussini A; Graziano G; Campana C; Bargiggia G; Angoli L; Aimè E; Arbustini E; Montemartini C
G Ital Cardiol; 1990 Feb; 20(2):114-22. PubMed ID: 2328864
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases.
Jais X; Launay D; Yaici A; Le Pavec J; Tchérakian C; Sitbon O; Simonneau G; Humbert M
Arthritis Rheum; 2008 Feb; 58(2):521-31. PubMed ID: 18240255
[TBL] [Abstract][Full Text] [Related]
7. Inhaled nitric oxide: effects on hemodynamics, myocardial contractility, and regional blood flow in dogs with mechanically induced pulmonary artery hypertension.
Girard C; Fargnoli JM; Godin-Ribuot D; Dutheil V; Maitrasse B; Girardet P; Arvieux CC
J Heart Lung Transplant; 1996 Jul; 15(7):700-8. PubMed ID: 8820786
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary hypertension in systemic lupus erythematosus: a report of three cases.
Asherson RA; Hackett D; Gharavi AE; Harris EN; Kennedy HG; Hughes GR
J Rheumatol; 1986 Apr; 13(2):416-20. PubMed ID: 3088276
[TBL] [Abstract][Full Text] [Related]
9. The response to inhaled nitric oxide in patients with pulmonary artery hypertension is not masked by baseline vasodilator use.
Krasuski RA; Wang A; Harrison JK; Tapson VF; Bashore TM
Am Heart J; 2005 Oct; 150(4):725-8. PubMed ID: 16209974
[TBL] [Abstract][Full Text] [Related]
10. Acute hemodynamic response to vasodilators in primary pulmonary hypertension.
Kulkarni H; Srinivas A; Vora A; Kerkar P; Dalvi B
J Postgrad Med; 1996; 42(1):7-11. PubMed ID: 9715289
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effects of S-nitrosocysteine, an intravenous regional vasodilator.
Stuesse DC; Giraud GD; Vlessis AA; Starr A; Trunkey DD
J Thorac Cardiovasc Surg; 2001 Aug; 122(2):371-7. PubMed ID: 11479512
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacologic effects of peripheral vasodilators in patients with secondary pulmonary hypertension].
Kukes VG; Tsoĭ AN; Abrosimov AG; Nasyrov ShN; Belov AM
Klin Med (Mosk); 1989 May; 67(5):52-6. PubMed ID: 2671486
[TBL] [Abstract][Full Text] [Related]
13. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
14. [Pulmonary artery hypertension and systemic lupus erythematosus. A case with hemodynamic study].
Haas C; Lowenstein W; Durand H
Ann Med Interne (Paris); 1990; 141(4):386-7. PubMed ID: 2240951
[No Abstract] [Full Text] [Related]
15. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary hypertension in systemic lupus erythematosus: hemodynamics and effects of vasodilator therapy.
Santini D; Fox D; Kloner RA; Konstam M; Rude RE; Lorell BH
Clin Cardiol; 1980 Dec; 3(6):406-11. PubMed ID: 7460402
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary hypertension and systemic lupus erythematosus.
Asherson RA; Oakley CM
J Rheumatol; 1986 Feb; 13(1):1-5. PubMed ID: 2871187
[No Abstract] [Full Text] [Related]
18. [Precapillary pulmonary arterial hypertension disclosing systemic lupus erythematosus].
Fauchier L; Goupille P; Babuty D; Marchal C; Valat JP; Fauchier JP; Cosnay P
Arch Mal Coeur Vaiss; 1996 Apr; 89(4):477-80. PubMed ID: 8763009
[TBL] [Abstract][Full Text] [Related]
19. [The effect of calcium antagonists on pulmonary hemodynamics in patients with chronic bronchitis with manifest and latent pulmonary hypertension].
Volkova LI
Ter Arkh; 1989; 61(8):50-3. PubMed ID: 2588166
[TBL] [Abstract][Full Text] [Related]
20. [Variable hemodynamic response to nifedipine in pulmonary hypertension secondary to chronic obstructive bronchopathy and pulmonary fibrosis].
Domenighetti G
Schweiz Med Wochenschr; 1985 Sep; 115(39):1345-7. PubMed ID: 4071009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
